Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens

被引:0
|
作者
Djordjevic, D
Nikolic, J
Stefanovic, V
机构
[1] Univ Nish, Sch Med, Inst Nephrol & Hemodialysis, YU-18000 Nish, Yugoslavia
[2] Univ Nish, Sch Med, Dept Neonatol, YU-18000 Nish, Yugoslavia
[3] Univ Nish, Sch Med, Inst Biochem, YU-18000 Nish, Yugoslavia
来源
PATHOLOGIE BIOLOGIE | 1998年 / 46卷 / 10期
关键词
ethanol; enzyme induction; drug interactions; toxic agent interactions;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Chronic ethanol abuse is associated with increased activity of the microsomal ethanol-oxidizing system. This effect is due primarily to induction by ethanol of a specific cytochrome P450 (CYP2E1) responsible for enhanced oxidation of ethanol and other P450 substrates and consequently, for metabolic tolerance to these substances. Furthermore, cytochrome 450 induction increases the activation of numerous xenobiotics to toxic metabolites and of chemical carcinogens to reactive metabolites, thereby accelerating their adverse effects. Microsomal enzyme induction has been associated with increased reactive oxygen species production and enhanced lipid peroxidation, as well as with decreased enzymatic and nonenzymatic scavenger activity, providing another possible explanation for ethanol-mediated toxicity. Yet another effect of chronic alcohol abuse is chronic immune system activation, which is the mechanism underlying alcohol-related liver disease. The metabolism of steroids and vitamins is catalyzed by P350 and is altered in chronic alcoholics. This article reviews recent advances in the understanding of ethanol interactions with drugs, toxic agents, and carcinogens, as well as with steroids and vitamins.
引用
收藏
页码:760 / 770
页数:11
相关论文
共 50 条
  • [31] The expression and substrates specificity of adrenal cytochrome P450
    Peng, RX
    Wang, H
    Zhang, YH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R418 - R418
  • [32] DIFFERENTIAL INTERACTIONS OF STEROIDOGENIC CYTOCHROME P450 17A1 WITH ITS SUBSTRATES
    Petrunak, Elyse M.
    DeVore, Natasha
    Scott, Emily E.
    DRUG METABOLISM REVIEWS, 2015, 47 : 70 - 70
  • [33] Pharmacokinetic Interactions of Rolapitant With Cytochrome P450 3A Substrates in Healthy Subjects
    Wang, Xiaodong
    Wang, Jing
    Arora, Sujata
    Hughes, Lorraine
    Christensen, Jennifer
    Lu, Sharon
    Zhang, Zhi-Yi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (04): : 488 - 499
  • [34] Prosubstrates of CYP3A4, the major human hepatic cytochrome P450 - Transformation into substrates by other P450 isoforms
    Stresser, DM
    Kupfer, D
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (11) : 1861 - 1871
  • [35] METABOLISM OF ETHANOL AND ASSOCIATED INTERACTIONS WITH OTHER DRUGS, CARCINOGENS, AND VITAMINS
    LIEBER, CS
    NEW YORK STATE JOURNAL OF MEDICINE, 1986, 86 (06) : 297 - 302
  • [36] Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5 enzymes
    Shimada, T
    Mernaugh, RL
    Guengerich, FP
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 435 (01) : 207 - 216
  • [37] DRUGS AS SUICIDE SUBSTRATES OF CYTOCHROME-P-450
    DEMATTEIS, F
    HUMAN TOXICOLOGY, 1986, 5 (02): : 110 - 111
  • [38] Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolisms
    Bostick, Chris D.
    Hickey, Katherine M.
    Wollenberg, Lance A.
    Flora, Darcy R.
    Tracy, Timothy S.
    Gannett, Peter M.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (05) : 741 - 749
  • [39] Pharmacovigilance: Effects of herbal components on human drugs interactions involving Cytochrome P450
    Saxena, Akansha
    Tripathi, Kumar Parijat
    Roy, Sudeep
    Khan, Feroz
    Sharma, Ashok
    BIOINFORMATION, 2008, 3 (05) : 198 - 204
  • [40] Cytochrome P450 induction - Drugs are not the only culprit
    Sharma, D
    Pfeifer, K
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 238 - 238